China Online Medicine Shares Tumble as Beijing Clarifies Rules
(Bloomberg) -- Shares of Chinese online health-care providers have been battered since the government released draft rules last week that deepened concerns about restrictions on growth potential for the sector.
Ping An Healthcare and Technology Co. has plummeted more than 30% while Alibaba Health Information Technology Ltd. has lost nearly 18% since the proposed regulations were published on Oct. 26. The two stocks are the worst performers in Hong Kong's Hang Seng Tech Index during the period. Rival JD Health International Inc. has dropped about 6%.
The draft rules, released by the National Health Commission to solicit public comments, clarified several issues -- including a ban on online consultations for initial diagnosis. Medical judgments must be conducted by a registered doctor, and artificial-intelligence software should not be used as a substitute, the rules said. Also, local governments must publish a list of approved providers to improve supervision.
“Companies will have to make sure everything is in compliance with the rules, which will likely slow down the growth of the sector,” said Carol Dou, an analyst at UOB Kay Hian Investment Co.
The tighter scrutiny of online health-care services signals that Beijing isn't done yet with its crackdown on private enterprises, which has targeted sectors from after-school tutoring to property development and gambling to gaming.
China's Tech Giants Take a Shot at Reinventing Health Care
Alibaba Health reported a preliminary net loss for April-September of as much as 320 million yuan ($50 million), or about 15% more than in the same period a year earlier. Meanwhile, Ping An Healthcare slashed its forecast for 2021 revenue growth to around 10% -- from around 30% previously -- according to a note published Friday by Citigroup Inc. analysts including John Yung.
The stock rout in the past week extended the months-long slump of internet health-care stocks amid calls by Chinese state media for ensuring the safety of online prescription-drug sales and tougher rules on how companies handle user data.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.